US, EU and Japan Announce Progress on Syncing Antibacterials Research

Drug Industry Daily
A A
The FDA, EMA and Japan’s Pharmaceuticals and Medical Devices Agency have made strides toward aligning clinical trial designs for antibacterial drug indications, the regulators announced following their fourth tripartite meeting in Tokyo.

To View This Article:

Login

Subscribe To Drug Industry Daily